Schedule 13G ownership disclosure

GH RESEARCH PLC

Ordinary Shares, nominal value $0.025 per share · CUSIP: G3855L106

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOTECHNOLOGY VALUE FUND L P

    Shares: 4,599,019.00 · Class: 7.4%

  • BVF I GP LLC

    Shares: 4,599,019.00 · Class: 7.4%

  • BIOTECHNOLOGY VALUE FUND II LP

    Shares: 3,605,399.00 · Class: 5.8%

  • BVF II GP LLC

    Shares: 3,605,399.00 · Class: 5.8%

  • Biotechnology Value Trading Fund OS LP

    Shares: 619,881.00 · Class: 1.0%

  • BVF Partners OS Ltd.

    Shares: 619,881.00 · Class: 1.0%

  • BVF GP HOLDINGS LLC

    Shares: 8,204,418.00 · Class: 13.2%

  • BVF PARTNERS L P/IL

    Shares: 8,827,712.00 · Class: 14.2%

  • BVF INC/IL

    Shares: 8,827,712.00 · Class: 14.2%

  • LAMPERT MARK N

    Shares: 8,827,712.00 · Class: 14.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000921895-25-001548
Form type
SCHEDULE 13G/A
Filer
BIOTECHNOLOGY VALUE FUND L P
CIK
CIK 918923
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub